Scholar Rock Holding (FRA:2QK) Days Payable: 0.00 (As of Mar. 2026)

What is Scholar Rock Holding Days Payable?

Scholar Rock Holding FRA:2QK +3.45% 28 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates FRA:2QK with a GF Score™ of 28/100. The stock has 5 warning signs investors should review. Among 702 Biotechnology companies, Scholar Rock Holding ranks worse than 142450% on this metric.

Scholar Rock Holding's average Accounts Payable for the three months ended in Mar. 2026 was €8.39 Mil. Scholar Rock Holding's Cost of Goods Sold for the three months ended in Mar. 2026 was €0.00 Mil.

The historical rank and industry rank for Scholar Rock Holding's Days Payable or its related term are showing as below:

FRA:2QK's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.56
* Ranked among companies with meaningful Days Payable only.

Scholar Rock Holding's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

Scholar Rock Holding Days Payable Related Terms

Scholar Rock Holding Days Payable Historical Data

* Premium members only.

The historical data trend for Scholar Rock Holding's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scholar Rock Holding Days Payable Chart

Scholar Rock Holding Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Days Payable

Get a 7-Day Free Trial

0.00

Scholar Rock Holding Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

FRA:2QK vs COGT, CGON, PTCT: Days Payable Comparison

For the Biotechnology subindustry, Scholar Rock Holding's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scholar Rock Holding Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scholar Rock Holding's Days Payable distribution charts can be found below:

* The bar in red indicates where Scholar Rock Holding's Days Payable falls into.

Save Embed

28GF Score

Scholar Rock Holding Corp FRA:2QK

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Scholar Rock Holding Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Scholar Rock Holding's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

	Days Payable (A: Dec. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2024 )	+	Accounts Payable (A: Dec. 2025 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2025 )	*	Days in Period
=	( (9.641	+	8.799)	/	2 )	/	0	*	365
=	9.22					/	0	*	365
=	N/A

Scholar Rock Holding's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

	Days Payable (Q: Mar. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2025 )	+	Accounts Payable (Q: Mar. 2026 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
=	( (8.799	+	7.974)	/	2 )	/	0	*	365 / 4
=	8.3865					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

Scholar Rock Holding (FRA:2QK) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Scholar Rock Holding and its competitors. According to the industry distribution chart, Scholar Rock Holding ranks #999999 out of 702 companies in the Biotechnology industry.

Is Scholar Rock Holding's Days Payable too high?

Scholar Rock Holding's current Days Payable is 0.00. Based on the distribution chart, Scholar Rock Holding ranks #999999 out of 702 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Scholar Rock Holding has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.

How does Scholar Rock Holding's Days Payable compare to COGT and CGON?

According to the Biotechnology industry distribution chart, Scholar Rock Holding ranks #999999 out of 702 companies for Days Payable. This places Scholar Rock Holding in the lower half of its industry. The industry median Days Payable is 113.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.56, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Scholar Rock Holding and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scholar Rock Holding's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Scholar Rock Holding stock overvalued right now?

Scholar Rock Holding (FRA:2QK) has a current Days Payable of 0.00. The current Days Payable is 0.00. Scholar Rock Holding's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Scholar Rock Holding (FRA:2QK), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scholar Rock Holding Business Description

Industry Healthcare Biotechnology

Comparable Companies COGT CGON PTCT LGND DFTX XENE RYTM LEGN MIRM SYRE VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges SRRK:USA 2QK:Germany

Address 301 Binney Street, 3rd Floor, Cambridge, MA, USA, 02142

Website https://www.scholarrock.com

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

28GF Score

Get the complete analysis for FRA:2QK

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€47.69

Price

View FRA:2QK Analysis

See Days Payable data for all stocks →